The feasibility of a collaborative double-blind study using an anticoagulant
JP Mohr,RL Sacco, J Fleiss,RM Lazar,JLP Thompson, D Gohs, L Lynn, D Burroughs, A Caputo, M Coleman,T Costigan, B Fields, G Kann, JS Kim, R King,W Ma, JL Ruzicka, K Slane, A Zidel,BC Tilley,R Sciacca,B Rosner,K Wende,B Levin,HP Adams,M Alter,JP Kistler,LC Pettigrew,P Pullicino,RL Brey,E Feldmann,SJ Kittner,V Babikian, SH Homma,M DiTullio, S Greenberg, M Trevisan,CM Fisher,HJM Barnett, JP Wisnant,JC Gautier,P Sandercock,P Karanjia,FS Buonanno,G Albers,F Nichols,J Grotta,C Helgason,M RamirezLassepas,S Tuhrim,M Pessin, A Culebras,C Sila,M Chimowitz, H Weinreb,L Brass,S Warach,C Kase,R Hamill,D Rosenbaum, J Hollander, C Johnson,K Gaines, M Yaseen,P Mitsias,R Libman,A Nafziger,A Forteza, A Miller,J Biller, H Kirschner, E Haley, J Binder, M Zalewski, D Jamieson, D Anderson, B Dandapani,L Lennihan, M Winkelman, R Hughes, C Jackson,B Boop,S Chaturvedi,J Rothrock, AZ Frey,ML Dyken, A Lowe,JR Marler,I Meissner,DG Sherman, DW Taylor,MD Walker Cerebrovascular Diseases（1997）
Key words
aspirin,anticoagulants,platelet aggregation,stroke outcome,warfarin,antiphospholipid antibodies,lupus anticoagulant,Patent Foramen Ovale,coagulation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper